NTX-109

N/A

Report date: 2025/01/26 17:37:58

Base Information

Drug NameNTX-109
Drug Alias NameBTK gene therapy (Noga Therapeutics)NTX-109
ClassificationBiologics
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAgammaglobulinemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNoga Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNoga Therapeutics LtdLonza Group AG
Inactive CompaniesN/A
Active IndicationsAgammaglobulinemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A